These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31979356)

  • 1. A Computational Approach for the Prediction of Treatment History and the Effectiveness or Failure of Antiretroviral Therapy.
    Tarasova O; Biziukova N; Kireev D; Lagunin A; Ivanov S; Filimonov D; Poroikov V
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
    Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
    J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
    [No Abstract]   [Full Text] [Related]  

  • 3. Automated prediction of HIV drug resistance from genotype data.
    Shen C; Yu X; Harrison RW; Weber IT
    BMC Bioinformatics; 2016 Aug; 17 Suppl 8(Suppl 8):278. PubMed ID: 27586700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence and structure based models of HIV-1 protease and reverse transcriptase drug resistance.
    Masso M; Vaisman II
    BMC Genomics; 2013; 14 Suppl 4(Suppl 4):S3. PubMed ID: 24268064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.
    Venturi G; Catucci M; Romano L; Corsi P; Leoncini F; Valensin PE; Zazzi M
    J Infect Dis; 2000 Feb; 181(2):740-5. PubMed ID: 10669367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insertions in the human immunodeficiency virus type 1 protease and reverse transcriptase genes: clinical impact and molecular mechanisms.
    Winters MA; Merigan TC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2575-82. PubMed ID: 15980322
    [No Abstract]   [Full Text] [Related]  

  • 7. A Computational Approach for the Prediction of HIV Resistance Based on Amino Acid and Nucleotide Descriptors.
    Tarasova O; Biziukova N; Filimonov D; Poroikov V
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30355996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
    de Baar MP; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1385-94. PubMed ID: 11018858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.
    Bakhouch K; Oulad-Lahcen A; Bensghir R; Blaghen M; Elfilali KM; Ezzikouri S; Abidi O; Hassar M; Wakrim L
    J Infect Dev Ctries; 2009 Jun; 3(5):380-91. PubMed ID: 19759509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.
    Gallego O; Ruiz L; Vallejo A; Ferrer E; Rubio A; Clotet B; Leal M; Soriano V;
    AIDS; 2001 Sep; 15(14):1894-6. PubMed ID: 11579258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 drug resistance in newly infected individuals.
    Boden D; Hurley A; Zhang L; Cao Y; Guo Y; Jones E; Tsay J; Ip J; Farthing C; Limoli K; Parkin N; Markowitz M
    JAMA; 1999 Sep 22-29; 282(12):1135-41. PubMed ID: 10501116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of HIV resistance mutations in the Valme referral center].
    Nogales MC; Castro C; Martín-Mazuelos E
    Enferm Infecc Microbiol Clin; 2007 Feb; 25(2):159. PubMed ID: 17288915
    [No Abstract]   [Full Text] [Related]  

  • 13. Algorithm specification interface for human immunodeficiency virus type 1 genotypic interpretation.
    Betts BJ; Shafer RW
    J Clin Microbiol; 2003 Jun; 41(6):2792-4. PubMed ID: 12791935
    [No Abstract]   [Full Text] [Related]  

  • 14. [Computational prediction of human immunodeficiency resistance to reverse transcriptase inhibitors].
    Tarasova OA; Filimonov DA; Poroikov VV
    Biomed Khim; 2017 Oct; 63(5):457-460. PubMed ID: 29080881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral Resistance Mutations (revised April 2001).
    ;
    HIV Clin Trials; 2001; 2(4):346-55. PubMed ID: 11590539
    [No Abstract]   [Full Text] [Related]  

  • 16. Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, Brazil.
    Pilcher CD; Perkins MD; Fiscus SA; Johnston DM; Dietze R; Duque UH; Zago AM; Assad-Antunes F; Eron JJ
    J Infect Dis; 1999 May; 179(5):1259-63. PubMed ID: 10191233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice.
    Romano L; Peduzzi C; Venturi G; Di Pietro M; Carli T; Corsi P; Gonnelli A; Valensin PE; Zazzi M
    J Acquir Immune Defic Syndr; 2002 Aug; 30(5):533-5. PubMed ID: 12154345
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice.
    Romano L; Venturi G; Giomi S; Pippi L; Valensin PE; Zazzi M
    J Med Virol; 2002 Feb; 66(2):143-50. PubMed ID: 11782921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
    Little SJ; Daar ES; D'Aquila RT; Keiser PH; Connick E; Whitcomb JM; Hellmann NS; Petropoulos CJ; Sutton L; Pitt JA; Rosenberg ES; Koup RA; Walker BD; Richman DD
    JAMA; 1999 Sep 22-29; 282(12):1142-9. PubMed ID: 10501117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral drug resistance among HIV-1 infected children failing treatment.
    Mullen J; Leech S; O'Shea S; Chrystie IL; Du Mont G; Ball C; Sharland M; Cottam F; Zuckerman M; Rice P; Easterbrook P
    J Med Virol; 2002 Nov; 68(3):299-304. PubMed ID: 12226814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.